Breathe Well Live Well
|
Europe Asthma Market Highlights – Analysis & Opportunities Report 2015-2020
PR Newswire (press release) Gain insights into how Europe asthma market will advance along with market forecast till 2020. Find out how asthma drugs will be positioned in Europe in 2020, with drug sales forecast and drug market share analysis for both marketed products and … Research and Markets: Europe Asthma Market Report – Analysis, Technologies … |
View full post on asthma – Google News
|
Research and Markets: Europe Asthma Market Report – Analysis, Technologies …
Business Wire (press release) The latest research, 'Europe Asthma Market Highlights – 2015', provides asthma market analysis, competitive landscape, and asthma drug sales forecast for Germany, France, Italy, Spain, and UK. The research includes Europe (Germany, France, Italy, Spain … |
View full post on asthma – Google News
Yahoo News |
Glaxo asthma drug clears key hurdle in Europe
MarketWatch LONDON–GlaxoSmithKline PLC's [GSK.LN] new severe-asthma medicine has received a positive opinion from the scientific committee of the European Medicines Agency for use in adults, clearing a key hurdle towards gaining marketing approval in Europe. EU regulator backs approval for GSK injectable asthma drug GlaxoSmithKline plc (ADR) To Lead Asthma Market GlaxoSmithKline's asthma injection heads for EU approval |
View full post on asthma – Google News
|
Rapid ragweed spread in Europe can cause severe allergies and asthma attacks
NYC Today In a recent warning, experts have drawn attention to the rapid spread of ragweed across Europe. According to experts, the pollen of ragweed can cause severe allergic reactions and trigger asthma attacks among people. Though ragweed is native to North … |
View full post on asthma – Google News
Express.co.uk |
The KILLER SMOG is BACK: Toxic pollution cloud from Europe to smother …
Express.co.uk People with asthma may also find they need to use their reliever inhaler more often. Older people should also reduce physical exertion. Anyone experiencing discomfort such as sore eyes, cough or sore throat should consider reducing activity … Bad air day sparks alert over asthma Toxic smog hits UK: Air pollution health alert is set trigger asthma attacks … Fatal asthma attack fears as Britain is placed on smog alert |
View full post on asthma – Google News
|
GSK Files For Approval Of Mepolizumab In US, Europe For Eosinophilic Asthma
Nasdaq The submissions include a Biologics Licence Application to the US Food and Drug Administration as an add-on maintenance treatment for severe eosinophilic asthma in patients aged 12 years and older with a history of exacerbations. It also comprises a … |
View full post on asthma – Google News
 |
Related Articles |
Specific inhalation challenge tests for occupational asthma in Europe: a survey.
Eur Respir Rev. 2014 Jun;23(132):266-70
Authors: Suojalehto H, Cullinan P, European Respiratory Society Task Force on Specific Inhalation Challenges with Occupational Agents
PMID: 24881084 [PubMed – in process]
View full post on pubmed: asthma
| Related Articles |
A Single-Nucleotide Polymorphism of Human Neuropeptide S Gene Originated from Europe Shows Decreased Bioactivity.
PLoS One. 2013;8(12):e83009
Authors: Deng C, He X, Hsueh AJ
Abstract
Using accumulating SNP (Single-Nucleotide Polymorphism) data, we performed a genome-wide search for polypeptide hormone ligands showing changes in the mature regions to elucidate genotype/phenotype diversity among various human populations. Neuropeptide S (NPS), a brain peptide hormone highly conserved in vertebrates, has diverse physiological effects on anxiety, fear, hyperactivity, food intake, and sleeping time through its cognate receptor-NPSR. Here, we report a SNP rs4751440 (L(6)-NPS) causing non-synonymous substitution on the 6(th) position (V to L) of the NPS mature peptide region. L(6)-NPS has a higher allele frequency in Europeans than other populations and probably originated from European ancestors ?25,000 yrs ago based on haplotype analysis and Approximate Bayesian Computation. Functional analyses indicate that L(6)-NPS exhibits a significant lower bioactivity than the wild type NPS, with ?20-fold higher EC50 values in the stimulation of NPSR. Additional evolutionary and mutagenesis studies further demonstrate the importance of the valine residue in the 6(th) position for NPS functions. Given the known physiological roles of NPS receptor in inflammatory bowel diseases, asthma pathogenesis, macrophage immune responses, and brain functions, our study provides the basis to elucidate NPS evolution and signaling diversity among human populations.
PMID: 24386135 [PubMed – as supplied by publisher]
View full post on pubmed: asthma
|
Asthma Drug Relva Approved In Europe, Japan, But Not The United States
The Inquisitr The United States has already approved the new Asthma drug but it's marketed as Breo in the United States. But US doctors are only allowed to prescribe Breo for chronic obstructive pulmonary disease (COPD) while Europe is recommending the new drug for … Relvar Ellipta Approved in Japan for Treatment of Asthma GSK, Theravance Announce Relvar Ellipta Approval In Japan For Asthma … Double asthma approval in Japan lifts SkyePharma |
View full post on asthma – Google News
|
COPD-asthma cases set to grow in Europe as people live longer
PMLiVE In an assessment of 845 people aged at least 85 in the UK, 20 per cent of men and 21 per cent of women had either asthma or COPD. But when participants undertook a spirometry test to measure lung function, 50 per cent of women showed airflow … NHS told to prepare for elderly COPD rise People aged 85 years and over have high burden of respiratory conditions |
View full post on asthma – Google News